Literature DB >> 7103445

Penetration of ceforanide and cefamandole into the right atrial appendage, pericardial fluid, sternum, and intercostal muscle of patients undergoing open heart surgery.

L D Mullany, M A French, C H Nightingale, H B Low, L H Ellison, R Quintiliani.   

Abstract

Doses of 30 mg of ceforanide or cefamandole per kg were administered intravenously to 26 patients just before their chests were opened for coronary artery bypass or cardiac valve replacement surgery. Samples of right atrial appendage, pericardial fluid, plasma, aortic wall, intercostal muscle, and sternum were obtained at different times after the antibiotic was injected, and these samples were assayed for cephalosporin concentration. For ceforanide the pre-bypass plasma half-life was 2.5 h, and the atrial appendage half-life was 2.1 h; for cefamandole the pre-bypass plasma half-life was 0.75 h and the atrial appendage half-life was 0.72 h. At 3 h the concentrations of ceforanide and cefamandole in atrial appendages were 28.0 and 5.0 micrograms/g, respectively. Ceforanide achieved higher and more sustained concentrations in other tissues than cefamandole. Considering the minimal inhibitory concentrations of these drugs for staphylococci, cefamandole and ceforanide should provide adequate protection against infection by these organisms for the duration of the surgical procedure.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7103445      PMCID: PMC181907          DOI: 10.1128/AAC.21.3.416

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement.

Authors:  B A Cunha; H R Gossling; H S Pasternak; C H Nightingale; R Quintiliani
Journal:  J Bone Joint Surg Am       Date:  1977-10       Impact factor: 5.284

2.  Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.

Authors:  J A Randolph; R E Buck; K E Price; F Leitner
Journal:  J Antibiot (Tokyo)       Date:  1979-07       Impact factor: 2.649

3.  Antibiotics and cardiac surgery.

Authors:  W A Reed
Journal:  J Thorac Cardiovasc Surg       Date:  1965-12       Impact factor: 5.209

4.  Effect of protein binding on the penetration of nonmetabolized cephalosporins into atrial appendage and pericardial fluids in open-heart surgical patients.

Authors:  C H Nightingale; J J Klimek; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

5.  Cefamandole: in vitro and clinical pharmacokinetics.

Authors:  R S Griffith; H R Black; G L Brier; J D Wolny
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

6.  A comparison of the penetration characteristics of cephapirin and cephalothin into right atrial appendage, muscle, fat, and pericardial fluid of pediatric patients undergoing open-heart operation.

Authors:  E R Green; S Subramanian; H Faden; R Quintiliani; C H Nightingale
Journal:  Ann Thorac Surg       Date:  1981-02       Impact factor: 4.330

7.  Comparison of cephalothin and cefamandole prophylaxis during insertion of prosthetic heart valves.

Authors:  G L Archer; R E Polk; R J Duma; R Lower
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

8.  Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity.

Authors:  F Leitner; M Misiek; T A Pursiano; R E Buck; D R Chisholm; R G DeRegis; Y H Tsai; K E Price
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

9.  Effect of cardiopulmonary bypass on cefazolin disposition.

Authors:  K W Miller; H G McCoy; K K Chan; R P Fischer; W G Lindsay; R D Seifert; D E Zaske
Journal:  Clin Pharmacol Ther       Date:  1980-04       Impact factor: 6.875

10.  Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans.

Authors:  F H Lee; M Pfeffer; D R Van Harken; R D Smyth; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

View more
  7 in total

1.  Antimicrobial prophylaxis of experimental endocarditis caused by Staphylococcus epidermidis.

Authors:  L M Baddour; M M Hill; A M Felty-Duckworth
Journal:  Infection       Date:  1989 Mar-Apr       Impact factor: 3.553

Review 2.  Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  D M Campoli-Richards; T E Lackner; J P Monk
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

Review 3.  Considerations in dosage selection for third generation cephalosporins.

Authors:  J H Yuk-Choi; C H Nightingale; T W Williams
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

4.  A comparative study of cefamandole and ceftriaxone as prophylaxis in cardiac surgery.

Authors:  P Neidhart; V Velebit; K Gunning; P M Suter
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

5.  Intraoperative ceforanide pharmacokinetics and protein binding.

Authors:  J T DiPiro; S M Bayoumi; J J Vallner; R R Nesbit; R Gokhale; J P Rissing
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

6.  Cefamandole prophylaxis for cardiovascular surgery: a dosage comparison.

Authors:  B J Zeluff; L O Gentry
Journal:  Tex Heart Inst J       Date:  1987-12

7.  Aztreonam penetration into synovial fluid and bone.

Authors:  C M MacLeod; E A Bartley; J O Galante; L T Friedhoff; R Dhruv
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.